We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$16.6B
AUM Growth
+$973M
Cap. Flow
-$466M
Cap. Flow %
-2.8%
Top 10 Hldgs %
30.85%
Holding
337
New
11
Increased
98
Reduced
190
Closed
11

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$43.9M
2
DELL icon
Dell
DELL
+$36.8M
3
CME icon
CME Group
CME
+$29.7M
4
AFG icon
American Financial Group
AFG
+$18.4M
5
WMB icon
Williams Companies
WMB
+$16.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$49.2M
2
AVGO icon
Broadcom
AVGO
+$43.2M
3
UPS icon
United Parcel Service
UPS
+$26.7M
4
PLD icon
Prologis
PLD
+$26.4M
5
ABT icon
Abbott
ABT
+$26M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 14.22%
3 Financials 13.06%
4 Industrials 12.03%
5 Consumer Staples 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
1
Broadcom
AVGO
$1.82T
$737M 4.43%
6,603,950
-455,820
-6% -$43.2M
PG icon
2
Procter & Gamble
PG
$343B
$622M 3.74%
4,243,445
-48,961
-1% -$7.25M
MSFT icon
3
Microsoft
MSFT
$2.84T
$556M 3.34%
1,479,068
-35,929
-2% -$12.8M
LLY icon
4
Eli Lilly
LLY
$1.07T
$523M 3.14%
896,569
-38,504
-4% -$22.5M
ABBV icon
5
AbbVie
ABBV
$458B
$518M 3.12%
3,343,889
-111,042
-3% -$16.2M
MRK icon
6
Merck
MRK
$324B
$466M 2.8%
4,271,961
-157,244
-4% -$16.3M
HD icon
7
Home Depot
HD
$332B
$448M 2.69%
1,291,401
-38,126
-3% -$11.8M
PEP icon
8
PepsiCo
PEP
$186B
$428M 2.57%
2,520,649
-94,229
-4% -$15.6M
MDLZ icon
9
Mondelez International
MDLZ
$77.7B
$422M 2.54%
5,832,772
+62,595
+1% +$4.29M
CVX icon
10
Chevron
CVX
$388B
$410M 2.46%
2,747,444
-87,630
-3% -$13.3M
APD icon
11
Air Products & Chemicals
APD
$66.3B
$402M 2.42%
1,467,674
-57,410
-4% -$15.8M
MRSH
12
Marsh
MRSH
$86.3B
$358M 2.15%
1,889,100
-69,949
-4% -$13.5M
NEE icon
13
NextEra Energy
NEE
$187B
$339M 2.04%
5,588,660
+40,212
+0.7% +$2.29M
MCD icon
14
McDonald's
MCD
$188B
$333M 2%
1,122,535
-38,145
-3% -$10.4M
TXN icon
15
Texas Instruments
TXN
$255B
$330M 1.98%
1,934,203
-135,460
-7% -$21M
PNC icon
16
PNC Financial Services
PNC
$100B
$325M 1.95%
2,097,593
-124,356
-6% -$16.1M
SRE icon
17
Sempra
SRE
$60.8B
$324M 1.95%
4,338,565
+54,592
+1% +$3.9M
ETN icon
18
Eaton
ETN
$157B
$322M 1.94%
1,338,321
-96,067
-7% -$21.2M
USB icon
19
US Bancorp
USB
$99.6B
$289M 1.73%
6,665,990
-392,025
-6% -$14.3M
PLD icon
20
Prologis
PLD
$138B
$279M 1.67%
2,089,418
-232,970
-10% -$26.4M
LMT icon
21
Lockheed Martin
LMT
$134B
$276M 1.66%
609,642
-21,453
-3% -$9.5M
SBUX icon
22
Starbucks
SBUX
$118B
$258M 1.55%
2,689,212
-137,156
-5% -$13.3M
WMB icon
23
Williams Companies
WMB
$90.5B
$244M 1.47%
7,018,863
+473,712
+7% +$16.6M
ADP icon
24
Automatic Data Processing
ADP
$100B
$232M 1.4%
997,785
-33,137
-3% -$7.72M
BR icon
25
Broadridge
BR
$17.2B
$223M 1.34%
1,082,210
+14,005
+1% +$2.58M

Similar funds

Bahl & Gaynor's Q4 2023 Portfolio in Review

As of Q4 2023, Bahl & Gaynor held 337 positions worth $16.6B, up 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2023 filing shows 11 new, 98 increased, 190 reduced and 11 closed positions. Its largest new stake was Dell: 520,900 shares worth $39.8M. The largest sale was Medtronic, an estimated $49.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2023 buy was Dell: 520,900 shares worth $39.8M.
  • Bahl & Gaynor added most to Amgen in Q4 2023, an estimated $43.9M increase.
  • Bahl & Gaynor's biggest Q4 2023 reduction was Medtronic, cutting an estimated $49.2M.
  • Bahl & Gaynor fully exited SBA Communications in Q4 2023, selling an estimated $375K.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2023.
  • Bahl & Gaynor opened 11 new positions and closed 11 in Q4 2023.
  • Bahl & Gaynor's portfolio value rose 6.2% quarter-over-quarter to $16.6B.

Based on Bahl & Gaynor's 13F filing for Q4 2023, filed 2 Feb 2024.